Biotechnologies

TRY 47.9 billion – 2.2 billion boxes

Size of Turkish pharmaceuticals market as December 2020.

USD 1.8 billion

Volume of Turkish pharmaceutical exports in 2020.

57

Number of accredited R&D centers in the Turkish life sciences industry as of June 2021.

1,603

Number of R&D employees in the Turkish pharmaceuticals industry as of 2020.

92%

Growth rate in Turkish pharmaceutical R&D spending between 2016-2019.

WHY INVEST IN BIOTECHNOLOGIES SECTOR IN İZMİR?

Favorable demographics with a dynamic, young and skilled talent pool supporting the industry

 

Heavy investments in healthcare infrastructure and services

 

Increasing life expectancy and spending in healthcare

 

Export opportunities due to Turkey’s proximity to regional markets

 

Ideal location for clinical trials and a favorable regulatory environment aligned with international standards

 

Global biotechnologies companies have been present in Turkey with significant manufacturing activities, using Turkey as a hub to access regional markets

BIOTECHNOLOGIES COMPANIES IN İZMİR

R&D INFRASTRUCTURES

İBG – İzmir Biomedicine and Genome Center’s mission is to develop innovative technologies and products for the prevention, diagnosis and treatment of diseases using basic research in life sciences as a driving force. IBG houses basic and translational research programs, technological research programs, industrial R&D programs working on biomedicine and genome sciences.

 

IBG has an enclosed space of approximately 22,250 m2, which includes the research laboratories, cell culture laboratories, equipped rooms for common use.